Paul Jensz
Follow
Get notifications in MyBN when activity occurs.
Paul Jensz
Executive Director / PAC Partners
Paul Jensz has experience across corporate strategy, healthcare networks and finance in emerging companies and the Australian, Asian and North American capital markets. He has also been focusing on emerging medtech ASX leaders.
Mr Jensz has worked with capital market leaders including CSL, Cochlear, Sonic Healthcare, Ramsay Healthcare, ResMed. He is an executive director of PAC Partners Securities, a specialist corporate broker focused on matching emerging companies; and is also executive chair of the Agfood Fund, an unlisted unit trust investing across the agribusiness and food supply chain sectors.
Mr Jensz has worked with capital market leaders including CSL, Cochlear, Sonic Healthcare, Ramsay Healthcare, ResMed. He is an executive director of PAC Partners Securities, a specialist corporate broker focused on matching emerging companies; and is also executive chair of the Agfood Fund, an unlisted unit trust investing across the agribusiness and food supply chain sectors.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 122nd | Compumedics | 80% | -0% |
| 537th | Whitefield | 8% | 8% |
| 1207th | Genetic Signatures | -33% | -9% |
| 1573rd | Revasum Inc | -57% | -41% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 586th |  | Compumedics | $43.0m |
| 680th | | Whitefield | $21.8m |
| 681st | | Revasum Inc | $21.8m |
| 683rd |  | Absolute Equity Performance Fund | $21.6m |
| 684th | | Genetic Signatures | $21.5m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Executive Director, PAC Partners | 27 Jan 2022 |
| NEW ROLE: Non-Executive Director, Compumedics | 27 Jan 2022 |
